BDMD Statistics
Total Valuation
BDMD has a market cap or net worth of $23.24 million. The enterprise value is $41.72 million.
| Market Cap | 23.24M |
| Enterprise Value | 41.72M |
Important Dates
The last earnings date was Thursday, September 3, 2026, before market open.
| Earnings Date | Sep 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BDMD has 42.21 million shares outstanding. The number of shares has increased by 35.98% in one year.
| Current Share Class | 42.21M |
| Shares Outstanding | 42.21M |
| Shares Change (YoY) | +35.98% |
| Shares Change (QoQ) | +7.36% |
| Owned by Insiders (%) | 43.29% |
| Owned by Institutions (%) | 1.05% |
| Float | 16.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.00 |
| PS Ratio | 0.95 |
| Forward PS | 1.32 |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | 5.60 |
| P/OCF Ratio | 5.60 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 10.06 |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.29 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | 4.55 |
| Interest Coverage | -20.07 |
Financial Efficiency
Return on equity (ROE) is -46.03% and return on invested capital (ROIC) is -26.99%.
| Return on Equity (ROE) | -46.03% |
| Return on Assets (ROA) | -11.88% |
| Return on Invested Capital (ROIC) | -26.99% |
| Return on Capital Employed (ROCE) | -36.80% |
| Weighted Average Cost of Capital (WACC) | 0.29% |
| Revenue Per Employee | $167,760 |
| Profits Per Employee | -$109,238 |
| Employee Count | 146 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.86 |
Taxes
In the past 12 months, BDMD has paid $1.17 million in taxes.
| Income Tax | 1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.94% in the last 52 weeks. The beta is -1.12, so BDMD's price volatility has been lower than the market average.
| Beta (5Y) | -1.12 |
| 52-Week Price Change | -64.94% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 18.21 |
| Average Volume (20 Days) | 75,039 |
Short Selling Information
The latest short interest is 26,899, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 26,899 |
| Short Previous Month | 25,463 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
In the last 12 months, BDMD had revenue of $24.49 million and -$15.95 million in losses. Loss per share was -$0.53.
| Revenue | 24.49M |
| Gross Profit | 20.97M |
| Operating Income | -14.33M |
| Pretax Income | -15.00M |
| Net Income | -15.95M |
| EBITDA | -13.33M |
| EBIT | -14.33M |
| Loss Per Share | -$0.53 |
Balance Sheet
The company has $397,194 in cash and $18.88 million in debt, with a net cash position of -$18.48 million or -$0.44 per share.
| Cash & Cash Equivalents | 397,194 |
| Total Debt | 18.88M |
| Net Cash | -18.48M |
| Net Cash Per Share | -$0.44 |
| Equity (Book Value) | 34.63M |
| Book Value Per Share | 1.09 |
| Working Capital | 10.18M |
Cash Flow
In the last 12 months, operating cash flow was $4.15 million and capital expenditures $2,295, giving a free cash flow of $4.15 million.
| Operating Cash Flow | 4.15M |
| Capital Expenditures | 2,295 |
| Depreciation & Amortization | 1.00M |
| Net Borrowing | -6.28M |
| Free Cash Flow | 4.15M |
| FCF Per Share | $0.10 |
Margins
Gross margin is 85.63%, with operating and profit margins of -58.52% and -65.12%.
| Gross Margin | 85.63% |
| Operating Margin | -58.52% |
| Pretax Margin | -61.25% |
| Profit Margin | -65.12% |
| EBITDA Margin | -54.42% |
| EBIT Margin | -58.52% |
| FCF Margin | 16.94% |
Dividends & Yields
BDMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -35.98% |
| Shareholder Yield | -35.98% |
| Earnings Yield | -68.64% |
| FCF Yield | 17.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BDMD has an Altman Z-Score of 0.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 3 |